tresir2012
Former Member
- Joined
- May 7, 2019
- Messages
- 11,156
- Reaction score
- 56,467
Loads have signed up to test vaccines.
COVID-19 vaccine trials attract more than 138,600 US volunteers
" "That’s why we’re optimistic that we’re going to be able to get the trials enrolled in an expeditious way. I think we can do what we need to do,” said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
The milestone was reached just a week after the National Institutes of Health launched a clinical trial network for vaccines and other prevention tools to fight the pandemic.
More are still needed, but the initial surge will go a long way toward filling the requirement for at least 30,000 volunteers each for the four companies that plan to launch Phase 3 clinical trials of their potential vaccines by early fall.
Together, the Moderna, Pfizer BioNTech, AstraZeneca and Inovio trials will require at least 120,000 volunteers.
“I would say it’s very encouraging at this stage,” said Barry Bloom, an immunologist and vaccine expert who is a professor of public health at the Harvard Chan School of Public Health.
'No one is safe until everyone is safe':Vaccine nationalism threatens global coronavirus effort
Regulation: FDA says a coronavirus vaccine would have to be at least 50% effective to be approved
Vaccine countdown: We're one-third of the way to a widely available coronavirus vaccine, experts say
Hundreds of clinical trials for drugs, medical devices and vaccines are going on across the United States at any one time, but most are relatively small. Putting together four large trials at the same time, with even more planned to come online later in the fall and winter, is a massive undertaking.
It doesn’t just require volunteers but also a robust complement of clinics, hospitals and medical centers around the nation with staff and physicians experienced in running clinical trials.
To make that happen, the NIH launched the COVID-19 Prevention Trials Network, merging four existing clinical trial networks. It launched on July 8 with a website where volunteers can sign up.
The network builds on decades worth of work creating clinical trial networks that goes back to the AIDS epidemic in the late 1980s, Fauci said.
“It would take literally years to build up a network that I’ve build up over the last 30 years. So why do it? We’re going to use what we have,” he said.
People chosen to take part will be racially, ethnically and geographically diverse. In its guidance for companies testing possible vaccines, the Food and Drug Administration says it wants the vaccine candidates to be tested in populations most affected by COVID-19, including ethnic and racial minorities, pregnant women, the elderly and people with underlying medical conditions that can worsen COVID-19."
Coronavirus (COVID-19) vaccine research studies - NHS
Vaccines are the most effective way to prevent infectious diseases.
They're designed so they do not give people the infection they're protecting against.
Research into vaccines is the only way to find out which vaccines will work. Researchers need people to take part in their studies so they can find out which possible new vaccine works best.
Information:
On this page you can sign up to be contacted about taking part in approved UK coronavirus vaccine studies. This means you'll be joining the COVID-19 vaccine research registry.
What's involved in vaccine studies
Vaccines are tested to make sure they're safe before being tested in people. If you take part in a vaccine study, you may or may not be offered the vaccine.
You'll need to visit the hospital, or other research site, a few times over 6 to 12 months.
At these visits, you'll usually:
- be told about the research study
- have the chance to ask any questions
- have blood tests
Who runs coronavirus vaccine studies
In England, the research partner of the NHS is the National Institute for Health Research (NIHR). The NIHR is working with equivalent NHS research partners in Northern Ireland, Scotland and Wales on vaccine studies.
If you sign up to be contacted about vaccine studies, only researchers on studies approved by NIHR will be able to contact you.
There are currently 2 national coronavirus vaccine studies approved by NIHR in the UK, run by the University of Oxford and Imperial College London.
You can find out more about taking part in these vaccine studies at NIHR's Be Part of Research website.
There are strict rules on safety and confidentiality that all health research, including vaccine studies, must follow.
How do I sign up?
You can sign up online.
We'll ask you some questions about yourself, and then ask your permission for researchers on the vaccine studies to contact you.
If you sign up, your details will be kept secure. They'll only be shared with researchers who think you might be suitable for a study they're working on.
The researchers will then contact you to tell you more about it.
You do not have to talk to researchers or take part in a study. It's your choice. If you sign up, you can withdraw your permission at any time.
Sign up to be contacted for coronavirus vaccine studies
If you have questions about signing up, see get help with signing up to be contacted for coronavirus vaccine research.
Take part in research
I am interested in who on here would be willing to sign up? I think I might.
Last edited:
